Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combigan and Latanoprost in Glaucoma or Ocular Hypertension
NCT00442312Phase 4Unknown
- Sponsor
- Genovate Biotechnology
- Start
- May 2006
- Countries
- 1
01
Overview
A Phase 4 trial of brimonidine tartrate + timolol maleate in Glaucoma, ocular hypertension, sponsored by Genovate Biotechnology. Status: unknown.
02
Drugs
brimonidine tartrate + timolol maleate
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT00442312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00442312.